Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA)
CUSIP: 640979100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 181,633,257
- Total 13F shares
- 63,827,298
- Share change
- +11,077,314
- Total reported value
- $627,414,966
- Put/Call ratio
- 41%
- Price per share
- $9.83
- Number of holders
- 92
- Value change
- +$100,142,866
- Number of buys
- 63
- Number of sells
- 32
Quarterly Holders Quick Answers
What is CUSIP 640979100?
CUSIP 640979100 identifies NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640979100:
Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
35,368,653
|
$423,716,463 | — | 19 Sep 2023 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
4.2%
|
7,646,916
|
$105,145,095 | — | 31 Mar 2024 | |
| FMR LLC |
13F
3/4/5
|
Company · Other* |
4.1%
|
7,482,365
|
$102,882,519 | — | 31 Mar 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
2.5%
|
4,460,700
|
$61,334,626 | — | 31 Mar 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
3,584,004
|
$49,281,000 | — | 31 Mar 2024 | |
| ICONIQ Capital, LLC |
13F
|
Company |
1.9%
|
3,398,628
|
$46,731,135 | — | 31 Mar 2024 | |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST |
13F
|
Company |
1.8%
|
3,309,123
|
$45,500,441 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.6%
|
2,924,052
|
$40,205,715 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
2,071,450
|
$28,482,438 | — | 31 Mar 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
1%
|
1,849,445
|
$25,429,869 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
1,823,983
|
$25,079,766 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.99%
|
1,800,000
|
$24,750,000 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.83%
|
1,500,000
|
$20,625,000 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.55%
|
1,000,000
|
$13,750,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.54%
|
985,571
|
$13,551,603 | — | 31 Mar 2024 | |
| SOROS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
904,016
|
$12,430,220 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.41%
|
752,924
|
$10,354,000 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.38%
|
688,169
|
$9,462,324 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.36%
|
646,118
|
$8,884,123 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.35%
|
633,851
|
$8,715,451 | — | 31 Mar 2024 | |
| Gosebruch Henry O |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
749,793
mixed-class rows
|
$7,065,720 | — | 14 Feb 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
452,381
|
$6,220,950 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.21%
|
382,345
|
$6,193,033 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.18%
|
334,330
|
$4,597,038 | — | 31 Mar 2024 | |
| Carol Y. Suh |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
544,674
mixed-class rows
|
$4,488,595 | — | 14 Feb 2024 | |
| Addis & Hill, Inc |
13F
|
Company |
0.17%
|
314,821
|
$4,187,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
259,184
|
$3,563,780 | — | 31 Mar 2024 | |
| Pier Capital, LLC |
13F
|
Company |
0.14%
|
249,336
|
$3,428,370 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.14%
|
248,595
|
$3,418,181 | — | 31 Mar 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.11%
|
204,987
|
$2,818,571 | — | 31 Mar 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.1%
|
187,811
|
$2,582,401 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
162,579
|
$2,235,461 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
150,000
|
$2,062,500 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
138,900
|
$1,910,000 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
136,828
|
$1,881,385 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
136,526
|
$1,877,232 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
124,542
|
$1,712,453 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
121,391
|
$1,669,127 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
110,194
|
$1,515,168 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.06%
|
110,000
|
$1,512,500 | — | 31 Mar 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
107,709
|
$1,480,999 | — | 31 Mar 2024 | |
| Auour Investments LLC |
13F
|
Company |
0.06%
|
105,087
|
$1,444,946 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.05%
|
98,300
|
$1,351,625 | — | 31 Mar 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.05%
|
91,656
|
$1,260,270 | — | 31 Mar 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.05%
|
82,853
|
$1,139,229 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
68,458
|
$941,298 | — | 31 Mar 2024 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.04%
|
65,973
|
$907,129 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
65,375
|
$898,908 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.03%
|
63,315
|
$870,581 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.03%
|
62,301
|
$856,639 | — | 31 Mar 2024 |
Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q2 2024
As of 30 Jun 2024,
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,827,298 shares.
The largest 10 holders included
FMR LLC, SOFTBANK GROUP CORP., T. Rowe Price Investment Management, Inc., BlackRock Inc., MIC Capital Management UK LLP, ICONIQ Capital, LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, VANGUARD GROUP INC, Artal Group S.A., and EcoR1 Capital, LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
86
Q2 2024 holders
92
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.